The distribution of glycoprotein B (gB) among different human herpesvirus 6 (HHV-6) strains was analysed with a panel of three monoclonal antibodies (MAbs) derived from mice immunized with U1102-infected lymphocytes. MAb 2D9 reacted specifically by immunofluorescence and immunoprecipitation with the Ul102 and GS isolates, and failed to react with Z29 and the variant B strains Hashimoto and SF. In addition, Z29, Hashimoto and SF gB had a lower M r than U1102 and GS gB. MAb 2D9 also failed to react with the exanthem subitum isolate CV, included in this study as an as yet poorly characterized isolate. Consistent with this result, CV failed to react with the variant A-specific MAb to gp82-105 and behaved as a variant B virus even with respect to the diagnostic HindIII endonuclease restriction cleavage site located in a fragment hybridizing to the pZVHI4 probe. By contrast with MAb 2D9, MAbs 2B9 and 2D10 reacted with all of the isolates tested, strengthening the argument that they have common epitopes. Based on the antigenic and M r specificities of gB, the HHV-6 isolates tested were arranged into two non-overlapping clusters, which closely parallel the variant A and B strain groups, defined previously by several criteria, including restriction endonuclease polymorphism, antigenic variations, growth in in vitro cultures and sequence analyses.
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Numerous isolates of the T lymphotropic human herpesviruses designated human herpesvirus 6 (HHV-6) have been described (Downing et al., 1987; Lopez et al., 1988; Tedder et al., 1987) . The first strains, GS, Ul102 and Z29, were derived from the peripheral blood of AIDS patients Downing et al., 1987; Lopez et al., 1988) . Subsequently, viruses similar to Z29 were derived from cases of exanthem subitum and shown to be the causative agents of the disease (Yamanishi et al., 1988) . Additional isolates were obtained from a number of pathological conditions as well as from healthy individuals (Pellett et al., 1992) . The U1102, GS and Z29 strains show cross-reactivity, a genome with an overlapping structure, identical base composition and size, and extensive cross-hybridization (Pellett et al., 1992) . The genomes of U1102 and GS and that of Z29 were found early to differ with respect to a HindIII restriction endonuclease site (Becker et al., 1989; Jarret et al., 1989; Josephs et al., 1988) located in a fragment hybridizing to the pZVH14 probe (Josephs et al., 1986) . Subsequently, the HHV-6 strains were differentiated into two clusters on the basis of several criteria, particularly restriction endonuclease cleavage pattern, reactivity to t Permanent address : Shandong Medical School, People's Republic of China. monoclonal antibodies (MAbs), growth in various cell lines in vitro Wyatt et al., 1990; Aubin et al., 1991 ; Schirmer et al., 1991 ; Ablashi et al., 1991) . The two clusters were designated variants A and B, ad interim, until more evidence is gained for the basis of the clustering and its biological and epidemiological significance (Ablashi et al., 1993) . GS and U1102 belong to variant group A, which includes adult-derived strains. Z29 is the prototype of variant group B, which includes isolates derived from children with roseola infantum. MAbs to gp82-105 and to p180 (Balachandran et al., 1989) react selectively with variant A strains; MAb OHV1 (Okuno et al., 1992) reacts specifically with variant B viruses (Aubin et al., 1993) . Comparative sequence analyses on restricted portions of the genomes of the two variant prototypes and of several strains showed that variations between variant A and B strains ranged from 4 to 6 %, and variations within each group ranged from 0-2 % to between 2 and 3 % (Aubin et al., 1993; Gompels et al., 1993) . These findings confirmed the very close relationship among the strains and strengthened the hypothesis of clustering of the HHV-6 isolates into two variant groups.
Earlier, our laboratory reported that MAb 2D10 reacts with a glycoprotein initially designated gl;l12 (Fo~t-Tomasi et al., 1992) , and subsequently shown to be the homologue of glycoprotein B (gB) encoded by HHV- 6 (Ellinger et al., 1993) . U1102-and GS-encoded gB were found to differ from the Z29 gB in that the former consist of three glycosylated polypeptides of M r 112000, 62000 and 58000, whereas the latter consists of three glycosylated polypeptides of M r 102000, 59000 and 50000 (Fofl-Tomasi et al., 1992) . For both U1102 and GS gB and Z29 gB the two lower M r polypeptides appear to be generated by proteolytic cleavage of the higher M r polypeptide (Fofl-Tomasi et al., 1992) . In this paper we derived two further MAbs to U1102 gB and examined the antigenic variations in the gB of a number of HHV-6 strains. We report that MAb 2D9 reacts specifically with GS and U1102 and does not react with Z29, the Hashimoto (Yamanishi et al., 1988) and SF (Levy et al., 1990) strains previously classified as B variants (Schirmer et al., 1991; Chandran et al., 1992) , nor with CV, an as yet poorly characterized isolate derived from a roseola infantum case (Portolani et al., 1990) . Our findings indicate that gB, a highly conserved glycoprotein within the Herpesviridae family, undergoes antigenic variations among the HHV-6 isolates tested. The clustering based on antigenic variations of gB parallels closely the segregation into variant groups A and B. MAbs 2B9 and 2D9 were derived from a mouse immunized with U 1102-infected cord blood lymphocytes (CBLs), as described previously for MAb 2E4 (Fo~t-Tomasi et al., 1991) . The hybridoma secreting MAb 2D 10 was derived independently of those secreting MAbs 2B9 and 2D9. All hybridomas were cloned twice. The culture of HHV-6 in CBLs has been described (FohTomasi et al., 1991) . The SF isolate was grown on peripheral blood lymphocytes. Labelling conditions were as follows. Infected CBLs were labelled for 12 h with [aSS]methionine (1300 Ci/mmol) at a concentration of 50 laCi/ml of medium containing 1/20 of the usual concentration of unlabelled methionine or labelled for 24 h with 6-D-[3H]glucosamine (33 Ci/mmol), at a concentration of 100 gCi/ml of medium containing onethird of the usual concentration of glucose. Pulse labelling was with [3H]gtucosamine (500 p.Ci/ml of medium containing no glucose) for 1 h. The proteins immunoprecipitated with the indicated MAbs were harvested with Protein A-Sepharose and electrophoretically separated in denaturing polyacrylamide gels, as detailed (Campadelli-Fiume et al., 1988) . The gels were soaked in Amplify (Amersham) and the dried gels were exposed to Kodak X-Omat films for fluorography. Indirect immunofluorescence analysis (IFA) of acetonefixed cells was as detailed (Fo/~-Tomasi et al., 1991) . electrophoretic profiles of the proteins immunoprecipitated from [3H]glucosamine-labelled HHV-6 (Ull02)-infected CBLs by MAbs 2B9, 2D9 and 2D10 were also practically indistinguishable (Fig. 1 b) . The only difference concerned an additional polypeptide, 88000 in apparent Mr, visible in the precipitates using MAb 2D9. To investigate the origin of this polypeptide a pulse-chase experiment was done. As shown in Fig.  l(c) , the M r 88000 polypeptide was absent in cells harvested after a 1 h pulse (lane 1), and became apparent in chased cells (lane 2), whereas both the M r 112000 precursor and the M r 62 000/58 000 cleaved polypeptides were already present in cells labelled for 1 h. The results suggest that the M r 88000 polypeptide originated by a post-translational event, probably by oligosaccharide conversion of one of the two low M r polypeptides to a higher M r polypeptide or by a late proteolytic cleavage.
The near identity of the electrophoretic profiles of the proteins immunoprecipitated by MAbs 2B9, 2D9 and 2D10 and by MAb to gp116-64-54 (Universal Biotechnology) (Fig. 1 b, lane 5) (Balachandran et al., 1989) suggested that the four MAbs react with one and the same glycoprotein. We took advantage of the ability of MAb 2D10 to react with denatured proteins to establish that this is indeed the case. Lysates of HHV-6 (U1102)-infected [35S]methionine-labelled CBLs were immunoprecipitated with MAbs 2B9, 2D9, 2D10 and MAbs to gp 116-64-54. The precipitated proteins were separated in denaturing gels, transferred to a nitrocellulose sheet and reacted with MAb 2D10. The ability of MAb 2D10 to react with the glycoproteins precipitated by any of the four MAbs (Fig. 2) indicates that MAbs 2B9, 2D9 and 2D10 all react with gB, and that the glycoprotein designated gp116-64-54 by Balachandran et al. (1989) is also gB. Previously, the epitopes reacting with MAbs 2D10 and 2B9 were shown to be present in a plasmidencoded product containing 79 amino acids from the Cterminal cytoplasmic tail of UI102 gB (Ellinger et al., 1993) . The lack of reactivity of MAb 2D10 to the M r 88 000 polypeptide in immunoblots (FoS.-Tomasi et al., 1992) favours the view that this polypeptide originates from the N-terminal rather than the C-terminal portion of the molecule. Consistent with this possibility is the observation that the N-terminal half of GS gB is more divergent than the C-terminal portion as compared to Z29 gB (Chou & Marousek, 1992) . The reported variations may well be sufficient to allow variations in epitopes, as single amino acid substitutions may account for lack of reactivity to antibody [see as an example MAb-resistant mutations in herpes simplex virus glycoprotein D (Minson et al., 1986) ] or for a strainspecific epitope [see for example human cytomegalovirus gH (Urban et al., 1992) ]. In addition, based on the ability of MAbs 2D10 and 2B9 to immnnoprecipitate both the 62000 and the 58 000 M r polypeptides, and on the strong similarities between Z29 gB (Fo~-Tomasi et al., 1992) and the protein recognized by MAb OHV 1 (Okuna et al., 1992) it can be assumed that the 62000 and 58000 M r polypeptides are disulphide-bonded. If this is the case, the absence of the 88000 M r polypeptide from the proteins immunoprecipitated by MAbs 2D10 and 2B9 would imply that, in the detergent-solubilized state, the 88000 Mr polypeptide lacks the epitope reacting with MAbs 2D10 and 2B9.
In the next series of experiments we investigated whether MAbs 2B9 and 2D9 can detect antigenic variations in gB expressed from various HHV-6 isolates. In addition to Ul102, the strains examined were GS, Z29, the Z29-1ike Hashimoto derived from a case of exanthem subitum (Yamanishi et al., 1988; Schirmer et al., 1991) , and the B variant SF, derived in San Francisco Short communication (i) (J) (t) from the saliva of a human immunodeficiency virus-(a) positive individual (Levy et al., 1990; Chandran et al., 1 1992) . The isolate CV, derived in Italy from a case of exanthem subitum (Portolani et al., 1990) , was included as an as yet poorly characterized HHV-6 isolate. By IFA MAb 2D9 reacted with cells infected with the U1102 and GS but failed to react with cells infected with the Z29, Hashimoto, SF and CV isolates (Fig. 3) . By contrast, ~ MAbs 2B9 and 2D10 reacted with cells infected with any isolate. The results indicate that MAb 2D9 specifically fails to react with Z29, Hashimoto, CV and SF. MAb anti-gp 116-64-54 reacted with all the isolates tested at a . . . . 100-fold dilution (data not shown), in agreement with previous data Ablashi et al., 1991) . !~ Previously, our laboratory reported that Z29 gB has a lower M~. than UI102 and GS gB (Fo~t-Tomasi et al., !~ 1992) . MAbs 2D10 and 2D9 were next tested in an immunoprecipitation assay with the above isolates. The objectives of this experiment were twofold: first, to ascertain whether the lower M r of Z29 gB is specific to this strain or is a variation common to variant B viruses; second, to ascertain whether the lack of reactivity of MAb 2D9 detected in IFA is reflected in an immunoprecipitation test. Lysates of [35S]methionine-labelled infected CBLs were immunoprecipitated with MAbs 2D10 and 2D9. The pattern of reactivity in immunoprecipitation reflected closely that in IFA, inasmuch as MAb 2D9 precipitated gB from U1102-and GS-infected CBLs, but failed to precipitate any protein from CBLs infected with the Z29, Hashimoto, SF or CV isolates ( Fig. 4) . MAb 2D 10 immunoprecipitated gB from CBLs infected with any isolate (Fig. 4) . The electrophoretic profile of the immunoprecipitated proteins revealed that gB expressed by Hashimoto, CV and SF consisted of three polypeptides similar in M r to those of Z29 gB. Two minor differences were observed. The higher M r band in Hashimoto gB appeared to consist not of one but of two polypeptides, of 102000 and 97000 apparent M r. The higher band in SF gB had an apparent M r of 98000. Since CV displayed the same reactivity to MAb 2D9 as Z29, we analysed the isolate for reactivity with the variant A-specific MAb to gp82-105 (Universal Biotechnology) and for the diagnostic variant B HindIII endonuclease restriction site. CV failed to react with the MAb (data not shown). The 830 bp fragment amplified by PCR according to Aubin et al. (1991) was cleaved by HindIII into two fragments (D. Di Luca & G. Campadelli-Fiume, unpublished) , indicating that CV may be classified as a variant B virus with respect to these two parameters.
Earlier, our laboratory identified the gB homologue encoded by U1102, GS and Z29 with the aid of MAb 2D10 (Ellinger et al., 1993) . In current studies we derived two additional MAbs (2B9 and 2D9) against HHV-6 gB and examined their reactivity with several HHV-6 strains. The relevant antibody in this study was MAb 2D9, which differs from MAbs 2D10 and 2B9 in its ability to immunoprecipitate an additional 88 000 M r polypeptide and in its specific reactivity with some of the isolates tested. The finding that HHV-6 gB was expressed by all the isolates is in agreement with the notion that gB, along with gH, is highly conserved in the Herpesviridae family.
Two co-variations were detected in gB encoded by the isolates tested. One concerned the selective reactivity of MAb 2D9, whose reacting epitope is either absent or modified in Z29, Hashimoto, SF and CV gB. The second variation concerned the lower apparent M r of Z29, Hashimoto, SF and CV gB, as compared to that of Ul102 and GS gB. The differences are likely to reflect differences in oligosaccharide content and/or processing, inasmuch as nucleotide sequence comparison between the GS and Z29 gB genes predicts no difference in the amino acid residue number but differences in the number of potential N-glycosylation sites (Chou & Marousek, 1992) . The two co-variations detected in gB allow clustering of HHV-6 isolates into two non-overlapping groups, one including GS and U1102, the other including Z29, the variant B strains Hashimoto and SF, and CV. The latter isolate was found to be similar to Z29 with respect to two further parameters, the lack of reactivity to the variant A-specific MAb to gp82-105 and the diagnostic HindIII endonuclease restriction site. Thus, the two HHV-6 clusters identified by analysis of gB are concordant with segregation into variants A and B (Ablashi et al., 1993) . Altogether, earlier and current studies show that the two clusters share common proteins and epitopes, and may be differentiated antigenically with respect to at least four proteins. It seems likely that the list of proteins containing epitopes specific for each cluster will increase as antibodies to additional proteins become available. Previous studies on the reactivity of MAb to gp82-105 and to p180 and of MAb OHV1 did not establish whether the lack of reactivity reflected the lack of the reactive epitope or a total lack of shared epitopes in the protein. Here we show that the variations occur within a conserved protein. Inasmuch as gB is an important component in virus entry for other herpesviruses and is a virion component in HHV-6 (Cirone et al., 1993) , the differences between variant A and variant B gB might correlate with the reported differences in host range specificities.
A large body of evidence has accumulated indicating that HHV-6 isolates may be clustered into two groups. Although the high degree of homology between the two variants might lead to recombination between the two genomes, such recombinants have not been recorded to date. The isolation of viruses characterized for an antigenic repertoire typical of variant A strains and displaying a mixed restriction pattern relative to a single HindlII restriction site (Ablashi et al., 1991 ; Dewhurst et al., 1992) argues for a dual isolation from the same host rather than for recombinants formed either in vivo or in vitro. We propose that MAb 2D9 should be employed in conjunction with the other variant-specific MAbs as diagnostic reagents to monitor HHV-6 isolates for antigenic composition and to establish a firm correlation between antigenic composition and genomic polymorphism and in vitro growth properties. For such a correlation to be significant, the number of antibodies should be high enough to detect variations in several regions of the genome; in this context there is a particular need for development of antibodies specific to the variant B strain group.
